FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313509637> ?p ?o ?g. }

• W4313509637 endingPage "352" @default.
• W4313509637 startingPage "352" @default.
• W4313509637 abstract "(1) Background: Secondary acute myeloid leukemia (AML), i.e., AML arising from prior therapy (therapy-related) and/or an antecedent hematologic disorder (AHD) is generally associated with worse outcomes compared to de novo AML. However, recognizing the prognostic importance of genetic characteristics rather than clinical history, secondary AML is now considered a diagnostic qualifier rather than a separate disease entity. (2) Methods: To assess the association between clinical history and AML outcomes in the context of allogeneic hematopoietic cell transplantation (HCT), we retrospectively analyzed 759 patients with de novo AML, 115 with AHD AML, and 105 with therapy-related AML who received first allografts while in first or second remission. (3) Results: At the time of HCT, these three cohorts differed significantly regarding many patient and disease-specific characteristics, including age (p < 0.001), gender (p < 0.001), disease risk (p = 0.005), HCT-CI score (p < 0.001), blood count recovery (p = 0.003), first vs. second remission (p < 0.001), remission duration (p < 0.001), measurable residual disease (MRD; p < 0.001), and conditioning intensity (p < 0.001). Relative to patients with de novo AML, relapse rates were similar for patients with AHD (hazard ratio [HR] = 1.07, p = 0.7) and therapy-related AML (HR = 0.86, p = 0.4) after multivariable adjustment, as were relapse-free survival (HR = 1.20, p = 0.2, and HR = 0.89, p = 0.5) and overall survival (HR = 1.19, p = 0.2, and HR = 0.93, p = 0.6). Non-relapse mortality was higher for AHD AML (HR = 1.59, p = 0.047). (4) Conclusions: These data suggest that the clinical history by itself contains limited prognostic value for adults with AML undergoing allografting, supporting the most recent approach to use this information as a diagnostic qualifier rather than a disease entity." @default.
• W4313509637 created "2023-01-06" @default.
• W4313509637 creator A5028772063 @default.
• W4313509637 creator A5044399026 @default.
• W4313509637 creator A5050374901 @default.
• W4313509637 creator A5056405520 @default.
• W4313509637 creator A5061769682 @default.
• W4313509637 creator A5084915025 @default.
• W4313509637 creator A5090388430 @default.
• W4313509637 date "2023-01-05" @default.
• W4313509637 modified "2023-10-01" @default.
• W4313509637 title "Association between Prior Cytotoxic Therapy, Antecedent Hematologic Disorder, and Outcome after Allogeneic Hematopoietic Cell Transplantation in Adult Acute Myeloid Leukemia" @default.
• W4313509637 cites W1563046611 @default.
• W4313509637 cites W1994791499 @default.
• W4313509637 cites W2027313932 @default.
• W4313509637 cites W2038242472 @default.
• W4313509637 cites W2071206691 @default.
• W4313509637 cites W2078310345 @default.
• W4313509637 cites W2099247435 @default.
• W4313509637 cites W2107027906 @default.
• W4313509637 cites W2107810465 @default.
• W4313509637 cites W2111724321 @default.
• W4313509637 cites W2116363536 @default.
• W4313509637 cites W2123331484 @default.
• W4313509637 cites W2128812336 @default.
• W4313509637 cites W2144395887 @default.
• W4313509637 cites W2214515641 @default.
• W4313509637 cites W2235843447 @default.
• W4313509637 cites W2290759365 @default.
• W4313509637 cites W2339658711 @default.
• W4313509637 cites W2559537906 @default.
• W4313509637 cites W2592670191 @default.
• W4313509637 cites W2605196669 @default.
• W4313509637 cites W2738685991 @default.
• W4313509637 cites W2883399820 @default.
• W4313509637 cites W2888263010 @default.
• W4313509637 cites W2908220713 @default.
• W4313509637 cites W2919327968 @default.
• W4313509637 cites W2948639458 @default.
• W4313509637 cites W2948786412 @default.
• W4313509637 cites W2989259738 @default.
• W4313509637 cites W2993336967 @default.
• W4313509637 cites W3002889628 @default.
• W4313509637 cites W3007376421 @default.
• W4313509637 cites W3009808643 @default.
• W4313509637 cites W3017099061 @default.
• W4313509637 cites W3017265630 @default.
• W4313509637 cites W3104531501 @default.
• W4313509637 cites W3195493284 @default.
• W4313509637 cites W3212294183 @default.
• W4313509637 cites W4205830254 @default.
• W4313509637 cites W4221096040 @default.
• W4313509637 cites W4283271244 @default.
• W4313509637 cites W4283716970 @default.
• W4313509637 cites W4284884567 @default.
• W4313509637 cites W4285390740 @default.
• W4313509637 cites W4293872788 @default.
• W4313509637 cites W4297537333 @default.
• W4313509637 cites W4307836700 @default.
• W4313509637 doi "https://doi.org/10.3390/cancers15020352" @default.
• W4313509637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36672303" @default.
• W4313509637 hasPublicationYear "2023" @default.
• W4313509637 type Work @default.
• W4313509637 citedByCount "0" @default.
• W4313509637 crossrefType "journal-article" @default.
• W4313509637 hasAuthorship W4313509637A5028772063 @default.
• W4313509637 hasAuthorship W4313509637A5044399026 @default.
• W4313509637 hasAuthorship W4313509637A5050374901 @default.
• W4313509637 hasAuthorship W4313509637A5056405520 @default.
• W4313509637 hasAuthorship W4313509637A5061769682 @default.
• W4313509637 hasAuthorship W4313509637A5084915025 @default.
• W4313509637 hasAuthorship W4313509637A5090388430 @default.
• W4313509637 hasBestOaLocation W43135096371 @default.
• W4313509637 hasConcept C126322002 @default.
• W4313509637 hasConcept C143998085 @default.
• W4313509637 hasConcept C151730666 @default.
• W4313509637 hasConcept C207103383 @default.
• W4313509637 hasConcept C2777408962 @default.
• W4313509637 hasConcept C2778461978 @default.
• W4313509637 hasConcept C2778729363 @default.
• W4313509637 hasConcept C2779134260 @default.
• W4313509637 hasConcept C2779343474 @default.
• W4313509637 hasConcept C2779823535 @default.
• W4313509637 hasConcept C2911091166 @default.
• W4313509637 hasConcept C44249647 @default.
• W4313509637 hasConcept C71924100 @default.
• W4313509637 hasConcept C86803240 @default.
• W4313509637 hasConcept C90924648 @default.
• W4313509637 hasConceptScore W4313509637C126322002 @default.
• W4313509637 hasConceptScore W4313509637C143998085 @default.
• W4313509637 hasConceptScore W4313509637C151730666 @default.
• W4313509637 hasConceptScore W4313509637C207103383 @default.
• W4313509637 hasConceptScore W4313509637C2777408962 @default.
• W4313509637 hasConceptScore W4313509637C2778461978 @default.
• W4313509637 hasConceptScore W4313509637C2778729363 @default.
• W4313509637 hasConceptScore W4313509637C2779134260 @default.
• W4313509637 hasConceptScore W4313509637C2779343474 @default.
• W4313509637 hasConceptScore W4313509637C2779823535 @default.

• next